Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Crestor Marks The End Of An Era, Should Quickly Outperform PCSK9s

May 02 2016

• By Mary Jo Laffler and Sue Sutter

Related Content

AstraZeneca gives Actavis generic Crestor head start

Mar 25 2013

UnitedHealth's Oxford Group Picks Praluent As First-Line PCSK9

Dec 02 2015

Lilly's Evacetrapib Raises More Doubts For HDL Theory

Apr 05 2016

Amgen's Statin Intolerance Study May Not Cure What Ails PCSK9 Inhibitors

Apr 04 2016

Amgen Earnings Beat Expectations; Company Pushing Payers On Repatha

Apr 29 2016

AZ Crows About Oncology Portfolio In 1Q; Strives For $1.1bn Cost Save

Apr 29 2016

Teva to buy Allergan Generics; Mylan off the hook but Perrigo still wriggling

Jul 27 2015

Related Companies

Allergan plc

AstraZeneca PLC

Teva Pharmaceutical Industries Ltd.

Allergan plc

Teva Pharmaceutical Industries Ltd.

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Pfizer Inc.

Daiichi Sankyo Co., Ltd.

Additional Topics

Companies Legal Issues Launches Cardiovascular

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window